Literature DB >> 23432363

Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV.

Stephanie Chiao1, Howard J Rosen, Krista Nicolas, Lauren A Wendelken, Oscar Alcantar, Katherine P Rankin, Bruce Miller, Victor Valcour.   

Abstract

A recent national survey of HIV(+) adults noted that nearly three-quarters of cognitively impaired individuals are categorized as having asymptomatic neurocognitive impairment (ANI), lacking documented compromise of everyday function. The clinical impact and long-term consequences of ANI are unknown and the importance of this asymptomatic diagnosis has raised concerns in clinical care settings where competing priorities often exist. In this study, we conducted structured tests of everyday functioning in a sample of HIV(+) subjects over 60 years of age and asked subjects to rate their performance relative to peers. We demonstrate that individuals with neuropsychological testing impairment often lack self-awareness of functional performance deficits. Specifically, ANI subjects rated functional performance similar to that of HIV-negative control subjects, despite noted deficits in objective measures of function. These findings have important implications for use of self-report of function in the diagnosis of HIV-associated neurocognitive disorders (HAND), likely underestimating symptomatic impairment.

Entities:  

Mesh:

Year:  2013        PMID: 23432363      PMCID: PMC3653396          DOI: 10.1089/AID.2012.0229

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  40 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

2.  The functional impact of HIV-associated neuropsychological impairment in Spanish-speaking adults: a pilot study.

Authors:  Monica Rivera Mindt; Mariana Cherner; Thomas D Marcotte; David J Moore; Heather Bentley; Maria M Esquivel; Yanira Lopez; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2003-02       Impact factor: 2.475

3.  Neuropsychiatric correlates of memory-metamemory dissociations in HIV-infection.

Authors:  S B Rourke; M H Halman; C Bassel
Journal:  J Clin Exp Neuropsychol       Date:  1999-12       Impact factor: 2.475

4.  Medication and finance management among HIV-infected adults: the impact of age and cognition.

Authors:  April D Thames; Michelle S Kim; Brian W Becker; Jessica M Foley; Lindsay J Hines; Elyse J Singer; Robert K Heaton; Steven A Castellon; Charles H Hinkin
Journal:  J Clin Exp Neuropsychol       Date:  2010-08-06       Impact factor: 2.475

Review 5.  Diagnostic evaluation of elderly patients with mild memory problems.

Authors:  Jason H T Karlawish; Christopher M Clark
Journal:  Ann Intern Med       Date:  2003-03-04       Impact factor: 25.391

6.  Effect of study partner on the conduct of Alzheimer disease clinical trials.

Authors:  Joshua D Grill; Rema Raman; Karin Ernstrom; Paul Aisen; Jason Karlawish
Journal:  Neurology       Date:  2012-12-19       Impact factor: 9.910

Review 7.  Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.

Authors:  Victor G Valcour; Cecilia M Shikuma; Michael R Watters; Ned C Sacktor
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

8.  The impact of HIV-associated neuropsychological impairment on everyday functioning.

Authors:  Robert K Heaton; Thomas D Marcotte; Monica Rivera Mindt; Joseph Sadek; David J Moore; Heather Bentley; J Allen McCutchan; Carla Reicks; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2004-05       Impact factor: 2.892

9.  Perceived barriers to social support from family and friends among older adults with HIV/AIDS.

Authors:  Eric W Schrimshaw; Karolynn Siegel
Journal:  J Health Psychol       Date:  2003-11

10.  Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.

Authors:  C H Hinkin; S A Castellon; R S Durvasula; D J Hardy; M N Lam; K I Mason; D Thrasher; M B Goetz; M Stefaniak
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

View more
  32 in total

Review 1.  Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.

Authors:  Benedetta Milanini; Victor Valcour
Journal:  Curr HIV/AIDS Rep       Date:  2017-08       Impact factor: 5.071

2.  Longitudinal brain atrophy patterns and neuropsychological performance in older adults with HIV-associated neurocognitive disorder compared with early Alzheimer's disease.

Authors:  Benedetta Milanini; Vishal Samboju; Yann Cobigo; Robert Paul; Shireen Javandel; Joanna Hellmuth; Isabel Allen; Bruce Miller; Victor Valcour
Journal:  Neurobiol Aging       Date:  2019-07-11       Impact factor: 4.673

3.  HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies.

Authors:  Mark R Etherton; Jennifer L Lyons; Kevin L Ard
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

4.  Self-predictions of prospective memory in HIV-associated neurocognitive disorders: evidence of a metamemory deficit.

Authors:  Kaitlin Blackstone Casaletto; Katie L Doyle; Erica Weber; Steven Paul Woods
Journal:  Arch Clin Neuropsychol       Date:  2014-12       Impact factor: 2.813

5.  White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV.

Authors:  Christa Watson; Edgar Busovaca; Jessica M Foley; I Elaine Allen; Christopher G Schwarz; Neda Jahanshad; Talia M Nir; Pardis Esmaeili-Firidouni; Benedetta Milanini; Howard Rosen; Owen T Carmichael; Paul M Thompson; Victor G Valcour
Journal:  J Neurovirol       Date:  2017-01-18       Impact factor: 2.643

6.  Abbreviated Goal Management Training Shows Preliminary Evidence as a Neurorehabilitation Tool for HIV-associated Neurocognitive Disorders among Substance Users.

Authors:  Kaitlin B Casaletto; David J Moore; Steven Paul Woods; Anya Umlauf; J C Scott; Robert K Heaton
Journal:  Clin Neuropsychol       Date:  2016-01-12       Impact factor: 3.535

7.  Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND.

Authors:  Lisa C Obermeit; Jessica Beltran; Kaitlin B Casaletto; Donald R Franklin; Scott Letendre; Ronald Ellis; Christine Fennema-Notestine; Florin Vaida; Ann C Collier; Christina M Marra; David Clifford; Benjamin Gelman; Ned Sacktor; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant; Robert K Heaton
Journal:  J Neurovirol       Date:  2016-08-24       Impact factor: 2.643

Review 8.  Cognitive Impairment and Persistent CNS Injury in Treated HIV.

Authors:  Phillip Chan; Joanna Hellmuth; Serena Spudich; Victor Valcour
Journal:  Curr HIV/AIDS Rep       Date:  2016-08       Impact factor: 5.071

9.  The Montreal cognitive assessment to screen for cognitive impairment in HIV patients older than 60 years.

Authors:  Benedetta Milanini; Lauren A Wendelken; Pardis Esmaeili-Firidouni; Maggie Chartier; Pierre-Cedric Crouch; Victor Valcour
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

Review 10.  HIV, aging, and cognition: emerging issues.

Authors:  Victor G Valcour
Journal:  Top Antivir Med       Date:  2013 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.